-
1
-
-
84988814923
-
HDV2 O-09: REP 2139 monotherapy and combination therapy with pegylated interferon: Safety and potent reduction of HBsAg and HDV RNA in Caucasian patients with chronic HBV/HDV co-infection
-
M. Bazinet, V. Pantea, V. Cebotarescu, L. Cojuhari, P. Jimbei, and A. Vaillant HDV2 O-09: REP 2139 monotherapy and combination therapy with pegylated interferon: safety and potent reduction of HBsAg and HDV RNA in Caucasian patients with chronic HBV/HDV co-infection J. Viral Hepat. 2015 5 6
-
(2015)
J. Viral Hepat.
, pp. 5-6
-
-
Bazinet, M.1
Pantea, V.2
Cebotarescu, V.3
Cojuhari, L.4
Jimbei, P.5
Vaillant, A.6
-
2
-
-
84921332527
-
Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
-
B. Bengsch, B. Martin, and R. Thimme Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation J. Hepatol. 6 2014 1212 1219
-
(2014)
J. Hepatol.
, vol.6
, pp. 1212-1219
-
-
Bengsch, B.1
Martin, B.2
Thimme, R.3
-
3
-
-
84944445841
-
T cell receptor-therapy in HBV-related hepatocellularcarcinoma
-
A. Bertoletti, M. Brunetto, M.K. Maini, F. Bonino, W. Qasim, and H. Stauss T cell receptor-therapy in HBV-related hepatocellularcarcinoma Oncoimmunology 4 2015
-
(2015)
Oncoimmunology
, vol.4
-
-
Bertoletti, A.1
Brunetto, M.2
Maini, M.K.3
Bonino, F.4
Qasim, W.5
Stauss, H.6
-
4
-
-
84935475377
-
Chronic hepatitis B: A wave of new therapies on the horizon
-
T.M. Block, S. Rawat, and C.L. Brosgart Chronic hepatitis B: a wave of new therapies on the horizon Antiviral Res. 2015 69 81
-
(2015)
Antiviral Res.
, pp. 69-81
-
-
Block, T.M.1
Rawat, S.2
Brosgart, C.L.3
-
5
-
-
37349056697
-
T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes
-
F. Bohne, M. Chmielewski, G. Ebert, K. Wiegmann, T. Kurschner, A. Schulze, S. Urban, M. Kronke, H. Abken, and U. Protzer T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes Gastroenterology 1 2008 239 247
-
(2008)
Gastroenterology
, vol.1
, pp. 239-247
-
-
Bohne, F.1
Chmielewski, M.2
Ebert, G.3
Wiegmann, K.4
Kurschner, T.5
Schulze, A.6
Urban, S.7
Kronke, M.8
Abken, H.9
Protzer, U.10
-
6
-
-
84866705034
-
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues
-
C. Boni, D. Laccabue, P. Lampertico, T. Giuberti, M. Vigano, S. Schivazappa, A. Alfieri, M. Pesci, G.B. Gaeta, G. Brancaccio, M. Colombo, G. Missale, and C. Ferrari Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues Gastroenterology 4 2012 963 973
-
(2012)
Gastroenterology
, vol.4
, pp. 963-973
-
-
Boni, C.1
Laccabue, D.2
Lampertico, P.3
Giuberti, T.4
Vigano, M.5
Schivazappa, S.6
Alfieri, A.7
Pesci, M.8
Gaeta, G.B.9
Brancaccio, G.10
Colombo, M.11
Missale, G.12
Ferrari, C.13
-
7
-
-
84861822888
-
Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model
-
M. Bourgine, S. Dion, O. Godon, G. Guillen, M.L. Michel, and J.C. Aguilar Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model Virology 1 2012 10 19
-
(2012)
Virology
, vol.1
, pp. 10-19
-
-
Bourgine, M.1
Dion, S.2
Godon, O.3
Guillen, G.4
Michel, M.L.5
Aguilar, J.C.6
-
9
-
-
84891490960
-
B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function
-
G. Cai, X. Nie, L. Li, L. Hu, B. Wu, J. Lin, C. Jiang, H. Wang, X. Wang, and Q. Shen B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function J. Gastroenterol. 12 2013 1362 1372
-
(2013)
J. Gastroenterol.
, vol.12
, pp. 1362-1372
-
-
Cai, G.1
Nie, X.2
Li, L.3
Hu, L.4
Wu, B.5
Lin, J.6
Jiang, C.7
Wang, H.8
Wang, X.9
Shen, Q.10
-
10
-
-
84980396144
-
Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result
-
S. Cai, T. Yu, Y. Jiang, Y. Zhang, F. Lv, and J. Peng Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result Clin. Exp. Med. 2015
-
(2015)
Clin. Exp. Med.
-
-
Cai, S.1
Yu, T.2
Jiang, Y.3
Zhang, Y.4
Lv, F.5
Peng, J.6
-
11
-
-
84872932013
-
Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure
-
D. Cao, H. Xu, G. Guo, Z. Ruan, L. Fei, Z. Xie, Y. Wu, and Y. Chen Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure Inflammation 1 2013 110 120
-
(2013)
Inflammation
, vol.1
, pp. 110-120
-
-
Cao, D.1
Xu, H.2
Guo, G.3
Ruan, Z.4
Fei, L.5
Xie, Z.6
Wu, Y.7
Chen, Y.8
-
12
-
-
79951866610
-
Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection
-
J.S. Cavenaugh, D. Awi, M. Mendy, A.V. Hill, H. Whittle, and S.J. McConkey Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection PLoS One 2 2011 e14626
-
(2011)
PLoS One
, vol.2
, pp. e14626
-
-
Cavenaugh, J.S.1
Awi, D.2
Mendy, M.3
Hill, A.V.4
Whittle, H.5
McConkey, S.J.6
-
13
-
-
84938368956
-
Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure
-
J. Chang, and J.T. Guo Treatment of chronic hepatitis B with pattern recognition receptor agonists: current status and potential for a cure Antiviral Res. 2015 152 159
-
(2015)
Antiviral Res.
, pp. 152-159
-
-
Chang, J.1
Guo, J.T.2
-
14
-
-
84869118771
-
The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy
-
J. Chang, T.M. Block, and J.T. Guo The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy Antiviral Res. 3 2012 405 413
-
(2012)
Antiviral Res.
, vol.3
, pp. 405-413
-
-
Chang, J.1
Block, T.M.2
Guo, J.T.3
-
15
-
-
84939947684
-
Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection
-
J.H. Chen, C.J. Perry, Y.C. Tsui, M.M. Staron, I.A. Parish, C.X. Dominguez, D.W. Rosenberg, and S.M. Kaech Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection Nat. Med. 4 2015 327 334
-
(2015)
Nat. Med.
, vol.4
, pp. 327-334
-
-
Chen, J.H.1
Perry, C.J.2
Tsui, Y.C.3
Staron, M.M.4
Parish, I.A.5
Dominguez, C.X.6
Rosenberg, D.W.7
Kaech, S.M.8
-
17
-
-
84910623522
-
2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor
-
M.H. Cho, H. Jeong, Y.S. Kim, J.W. Kim, and G. Jung 2-amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor J. Viral Hepat. 12 2014 843 852
-
(2014)
J. Viral Hepat.
, vol.12
, pp. 843-852
-
-
Cho, M.H.1
Jeong, H.2
Kim, Y.S.3
Kim, J.W.4
Jung, G.5
-
18
-
-
84945458736
-
Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy
-
Y.E. Chon, B. Jin, S.H. Ahn, S. Kim, N.D. Kim, J.H. Park, C.M. Nam, K.H. Kim, S.P. Hong, S.H. Choi, D.Y. Kim, J.Y. Park, and K.H. Han Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy Liver Int. 2015
-
(2015)
Liver Int.
-
-
Chon, Y.E.1
Jin, B.2
Ahn, S.H.3
Kim, S.4
Kim, N.D.5
Park, J.H.6
Nam, C.M.7
Kim, K.H.8
Hong, S.P.9
Choi, S.H.10
Kim, D.Y.11
Park, J.Y.12
Han, K.H.13
-
19
-
-
84874727114
-
A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice
-
M.A. Cobleigh, X. Wei, and M.D. Robek A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice J. Virol. 5 2013 2969 2973
-
(2013)
J. Virol.
, vol.5
, pp. 2969-2973
-
-
Cobleigh, M.A.1
Wei, X.2
Robek, M.D.3
-
20
-
-
84872189529
-
The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection
-
K.D. Cook, and J.K. Whitmire The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection J. Immunol. 2 2013 641 649
-
(2013)
J. Immunol.
, vol.2
, pp. 641-649
-
-
Cook, K.D.1
Whitmire, J.K.2
-
21
-
-
79955088827
-
Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: A review of HEPLISAV safety and efficacy
-
C. Cooper, and D. Mackie Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV safety and efficacy Expert Rev. Vaccines 4 2011 417 427
-
(2011)
Expert Rev. Vaccines
, vol.4
, pp. 417-427
-
-
Cooper, C.1
Mackie, D.2
-
22
-
-
42549152118
-
CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years
-
C.L. Cooper, J.B. Angel, I. Seguin, H.L. Davis, and D.W. Cameron CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years Clin. Infect. Dis. 8 2008 1310 1314
-
(2008)
Clin. Infect. Dis.
, vol.8
, pp. 1310-1314
-
-
Cooper, C.L.1
Angel, J.B.2
Seguin, I.3
Davis, H.L.4
Cameron, D.W.5
-
23
-
-
62749092550
-
Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12
-
J. Crettaz, I. Otano, L. Ochoa-Callejero, A. Benito, A. Paneda, I. Aurrekoetxea, P. Berraondo, J.R. Rodriguez-Madoz, A. Astudillo, F. Kreppel, S. Kochanek, J. Ruiz, S. Menne, J. Prieto, and G. Gonzalez-Aseguinolaza Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12 J. Virol. 6 2009 2663 2674
-
(2009)
J. Virol.
, vol.6
, pp. 2663-2674
-
-
Crettaz, J.1
Otano, I.2
Ochoa-Callejero, L.3
Benito, A.4
Paneda, A.5
Aurrekoetxea, I.6
Berraondo, P.7
Rodriguez-Madoz, J.R.8
Astudillo, A.9
Kreppel, F.10
Kochanek, S.11
Ruiz, J.12
Menne, S.13
Prieto, J.14
Gonzalez-Aseguinolaza, G.15
-
24
-
-
84892856584
-
Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads
-
K.K. Dietze, G. Zelinskyy, J. Liu, F. Kretzmer, S. Schimmer, and U. Dittmer Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads PLoS Pathog. 12 2013 e1003798
-
(2013)
PLoS Pathog.
, vol.12
, pp. e1003798
-
-
Dietze, K.K.1
Zelinskyy, G.2
Liu, J.3
Kretzmer, F.4
Schimmer, S.5
Dittmer, U.6
-
25
-
-
84927513847
-
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
-
C. Dong, L. Qu, H. Wang, L. Wei, Y. Dong, and S. Xiong Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication Antiviral Res. 2015 110 117
-
(2015)
Antiviral Res.
, pp. 110-117
-
-
Dong, C.1
Qu, L.2
Wang, H.3
Wei, L.4
Dong, Y.5
Xiong, S.6
-
26
-
-
36749061308
-
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion
-
A.M. Dougherty, H. Guo, G. Westby, Y. Liu, E. Simsek, J.T. Guo, A. Mehta, P. Norton, B. Gu, T. Block, and A. Cuconati A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion Antimicrob. Agents Chemother. 12 2007 4427 4437
-
(2007)
Antimicrob. Agents Chemother.
, vol.12
, pp. 4427-4437
-
-
Dougherty, A.M.1
Guo, H.2
Westby, G.3
Liu, Y.4
Simsek, E.5
Guo, J.T.6
Mehta, A.7
Norton, P.8
Gu, B.9
Block, T.10
Cuconati, A.11
-
27
-
-
34548641466
-
The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging
-
J.J. Feld, D. Colledge, V. Sozzi, R. Edwards, M. Littlejohn, and S.A. Locarnini The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging Antiviral Res. 2 2007 168 177
-
(2007)
Antiviral Res.
, vol.2
, pp. 168-177
-
-
Feld, J.J.1
Colledge, D.2
Sozzi, V.3
Edwards, R.4
Littlejohn, M.5
Locarnini, S.A.6
-
28
-
-
77958156535
-
The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines
-
F. Feng, C.Q. Teoh, Q. Qiao, D. Boyle, and A.R. Jilbert The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines Vaccine 46 2010 7436 7443
-
(2010)
Vaccine
, vol.46
, pp. 7436-7443
-
-
Feng, F.1
Teoh, C.Q.2
Qiao, Q.3
Boyle, D.4
Jilbert, A.R.5
-
29
-
-
84869880461
-
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV
-
P. Fisicaro, C. Valdatta, M. Massari, E. Loggi, L. Ravanetti, S. Urbani, T. Giuberti, A. Cavalli, C. Vandelli, P. Andreone, G. Missale, and C. Ferrari Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV Gastroenterology 6 2012 1576 1585
-
(2012)
Gastroenterology
, vol.6
, pp. 1576-1585
-
-
Fisicaro, P.1
Valdatta, C.2
Massari, M.3
Loggi, E.4
Ravanetti, L.5
Urbani, S.6
Giuberti, T.7
Cavalli, A.8
Vandelli, C.9
Andreone, P.10
Missale, G.11
Ferrari, C.12
-
30
-
-
84872035154
-
Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B
-
S.P. Fletcher, D.J. Chin, D.T. Cheng, P. Ravindran, H. Bitter, L. Gruenbaum, P.J. Cote, H. Ma, K. Klumpp, and S. Menne Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B Hepatology 1 2013 13 22
-
(2013)
Hepatology
, vol.1
, pp. 13-22
-
-
Fletcher, S.P.1
Chin, D.J.2
Cheng, D.T.3
Ravindran, P.4
Bitter, H.5
Gruenbaum, L.6
Cote, P.J.7
Ma, H.8
Klumpp, K.9
Menne, S.10
-
31
-
-
84883746616
-
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
-
M.J. Fuller, B. Callendret, B. Zhu, G.J. Freeman, D.L. Hasselschwert, W. Satterfield, A.H. Sharpe, L.B. Dustin, C.M. Rice, A. Grakoui, R. Ahmed, and C.M. Walker Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1) Proc. Natl. Acad. Sci. USA 37 2013 15001 15006
-
(2013)
Proc. Natl. Acad. Sci. USA
, vol.37
, pp. 15001-15006
-
-
Fuller, M.J.1
Callendret, B.2
Zhu, B.3
Freeman, G.J.4
Hasselschwert, D.L.5
Satterfield, W.6
Sharpe, A.H.7
Dustin, L.B.8
Rice, C.M.9
Grakoui, A.10
Ahmed, R.11
Walker, C.M.12
-
32
-
-
84935451137
-
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
-
E.J. Gane, Y.S. Lim, S.C. Gordon, K. Visvanathan, E. Sicard, R.N. Fedorak, S. Roberts, B. Massetto, Z. Ye, S. Pflanz, K.L. Garrison, A. Gaggar, S.G. Mani, J.G. McHutchison, S. Kottilil, B. Freilich, C.S. Coffin, W. Cheng, and Y.J. Kim The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection J. Hepatol. 2 2015 320 328
-
(2015)
J. Hepatol.
, vol.2
, pp. 320-328
-
-
Gane, E.J.1
Lim, Y.S.2
Gordon, S.C.3
Visvanathan, K.4
Sicard, E.5
Fedorak, R.N.6
Roberts, S.7
Massetto, B.8
Ye, Z.9
Pflanz, S.10
Garrison, K.L.11
Gaggar, A.12
Mani, S.G.13
McHutchison, J.G.14
Kottilil, S.15
Freilich, B.16
Coffin, C.S.17
Cheng, W.18
Kim, Y.J.19
-
33
-
-
84878089612
-
A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection
-
D. Gardiner, J. Lalezari, E. Lawitz, M. DiMicco, R. Ghalib, K.R. Reddy, K.M. Chang, M. Sulkowski, S.O. Marro, J. Anderson, B. He, V. Kansra, F. McPhee, M. Wind-Rotolo, D. Grasela, M. Selby, A.J. Korman, and I. Lowy A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection PLoS One 5 2013 e63818
-
(2013)
PLoS One
, vol.5
, pp. e63818
-
-
Gardiner, D.1
Lalezari, J.2
Lawitz, E.3
DiMicco, M.4
Ghalib, R.5
Reddy, K.R.6
Chang, K.M.7
Sulkowski, M.8
Marro, S.O.9
Anderson, J.10
He, B.11
Kansra, V.12
McPhee, F.13
Wind-Rotolo, M.14
Grasela, D.15
Selby, M.16
Korman, A.J.17
Lowy, I.18
-
34
-
-
79958840661
-
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines
-
A.J. Gehring, S.A. Xue, Z.Z. Ho, D. Teoh, C. Ruedl, A. Chia, S. Koh, S.G. Lim, M.K. Maini, H. Stauss, and A. Bertoletti Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines J. Hepatol. 1 2011 103 110
-
(2011)
J. Hepatol.
, vol.1
, pp. 103-110
-
-
Gehring, A.J.1
Xue, S.A.2
Ho, Z.Z.3
Teoh, D.4
Ruedl, C.5
Chia, A.6
Koh, S.7
Lim, S.G.8
Maini, M.K.9
Stauss, H.10
Bertoletti, A.11
-
36
-
-
84940195264
-
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities
-
R.G. Gish, B.D. Given, C.L. Lai, S.A. Locarnini, J.Y. Lau, D.L. Lewis, and T. Schluep Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities Antiviral Res. 2015 47 58
-
(2015)
Antiviral Res.
, pp. 47-58
-
-
Gish, R.G.1
Given, B.D.2
Lai, C.L.3
Locarnini, S.A.4
Lau, J.Y.5
Lewis, D.L.6
Schluep, T.7
-
37
-
-
84936972906
-
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent
-
R.G. Gish, M.F. Yuen, H.L. Chan, B.D. Given, C.L. Lai, S.A. Locarnini, J.Y. Lau, C.I. Wooddell, T. Schluep, and D.L. Lewis Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent Antiviral Res. 2015 97 108
-
(2015)
Antiviral Res.
, pp. 97-108
-
-
Gish, R.G.1
Yuen, M.F.2
Chan, H.L.3
Given, B.D.4
Lai, C.L.5
Locarnini, S.A.6
Lau, J.Y.7
Wooddell, C.I.8
Schluep, T.9
Lewis, D.L.10
-
38
-
-
0033617583
-
Viral clearance without destruction of infected cells during acute HBV infection
-
L.G. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F.V. Chisari Viral clearance without destruction of infected cells during acute HBV infection Science 284 1999 825 829
-
(1999)
Science
, vol.284
, pp. 825-829
-
-
Guidotti, L.G.1
Rochford, R.2
Chung, J.3
Shapiro, M.4
Purcell, R.5
Chisari, F.V.6
-
39
-
-
84940183673
-
Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics
-
J.T. Guo, and H. Guo Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics Antiviral Res. 2015 91 100
-
(2015)
Antiviral Res.
, pp. 91-100
-
-
Guo, J.T.1
Guo, H.2
-
40
-
-
70349568358
-
A lymphotoxin-driven pathway to hepatocellular carcinoma
-
J. Haybaeck, N. Zeller, M.J. Wolf, A. Weber, U. Wagner, M.O. Kurrer, J. Bremer, G. Iezzi, R. Graf, P.A. Clavien, R. Thimme, H. Blum, S.A. Nedospasov, K. Zatloukal, M. Ramzan, S. Ciesek, T. Pietschmann, P.N. Marche, M. Karin, M. Kopf, J.L. Browning, A. Aguzzi, and M. Heikenwalder A lymphotoxin-driven pathway to hepatocellular carcinoma Cancer Cell 4 2009 295 308
-
(2009)
Cancer Cell
, vol.4
, pp. 295-308
-
-
Haybaeck, J.1
Zeller, N.2
Wolf, M.J.3
Weber, A.4
Wagner, U.5
Kurrer, M.O.6
Bremer, J.7
Iezzi, G.8
Graf, R.9
Clavien, P.A.10
Thimme, R.11
Blum, H.12
Nedospasov, S.A.13
Zatloukal, K.14
Ramzan, M.15
Ciesek, S.16
Pietschmann, T.17
Marche, P.N.18
Karin, M.19
Kopf, M.20
Browning, J.L.21
Aguzzi, A.22
Heikenwalder, M.23
more..
-
41
-
-
0028874048
-
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
-
D.D. Ho, A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 6510 1995 123 126
-
(1995)
Nature
, vol.6510
, pp. 123-126
-
-
Ho, D.D.1
Neumann, A.U.2
Perelson, A.S.3
Chen, W.4
Leonard, J.M.5
Markowitz, M.6
-
42
-
-
84872134939
-
Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice
-
M. Huang, R. Sun, H. Wei, and Z. Tian Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice Hepatology 1 2013 277 288
-
(2013)
Hepatology
, vol.1
, pp. 277-288
-
-
Huang, M.1
Sun, R.2
Wei, H.3
Tian, Z.4
-
43
-
-
19944428132
-
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial
-
H.L. Janssen, M. van Zonneveld, H. Senturk, S. Zeuzem, U.S. Akarca, Y. Cakaloglu, C. Simon, T.M. So, G. Gerken, R.A. de Man, H.G. Niesters, P. Zondervan, B. Hansen, and S.W. Schalm Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial Lancet 9454 2005 123 129
-
(2005)
Lancet
, vol.9454
, pp. 123-129
-
-
Janssen, H.L.1
Van Zonneveld, M.2
Senturk, H.3
Zeuzem, S.4
Akarca, U.S.5
Cakaloglu, Y.6
Simon, C.7
So, T.M.8
Gerken, G.9
De Man, R.A.10
Niesters, H.G.11
Zondervan, P.12
Hansen, B.13
Schalm, S.W.14
-
44
-
-
83455246039
-
Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B
-
X. Jiang, M. Zhang, Q. Lai, X. Huang, Y. Li, J. Sun, W.G. Abbott, S. Ma, and J. Hou Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B PLoS One 12 2011 e28871
-
(2011)
PLoS One
, vol.12
, pp. e28871
-
-
Jiang, X.1
Zhang, M.2
Lai, Q.3
Huang, X.4
Li, Y.5
Sun, J.6
Abbott, W.G.7
Ma, S.8
Hou, J.9
-
45
-
-
84903482908
-
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver
-
J. Jo, A.T. Tan, J.E. Ussher, E. Sandalova, X.Z. Tang, A. Tan-Garcia, N. To, M. Hong, A. Chia, U.S. Gill, P.T. Kennedy, K.C. Tan, K.H. Lee, G. De Libero, A.J. Gehring, C.B. Willberg, P. Klenerman, and A. Bertoletti Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver PLoS Pathog. 6 2014 e1004210
-
(2014)
PLoS Pathog.
, vol.6
, pp. e1004210
-
-
Jo, J.1
Tan, A.T.2
Ussher, J.E.3
Sandalova, E.4
Tang, X.Z.5
Tan-Garcia, A.6
To, N.7
Hong, M.8
Chia, A.9
Gill, U.S.10
Kennedy, P.T.11
Tan, K.C.12
Lee, K.H.13
De Libero, G.14
Gehring, A.J.15
Willberg, C.B.16
Klenerman, P.17
Bertoletti, A.18
-
46
-
-
77549086947
-
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
-
Y. Ju, N. Hou, J. Meng, X. Wang, X. Zhang, D. Zhao, Y. Liu, F. Zhu, L. Zhang, W. Sun, X. Liang, L. Gao, and C. Ma T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B J. Hepatol. 3 2010 322 329
-
(2010)
J. Hepatol.
, vol.3
, pp. 322-329
-
-
Ju, Y.1
Hou, N.2
Meng, J.3
Wang, X.4
Zhang, X.5
Zhao, D.6
Liu, Y.7
Zhu, F.8
Zhang, L.9
Sun, W.10
Liang, X.11
Gao, L.12
Ma, C.13
-
47
-
-
0034596944
-
Natural killer T cell activation inhibits hepatitis B virus replication in vivo
-
K. Kakimi, L.G. Guidotti, Y. Koezuka, and F.V. Chisari Natural killer T cell activation inhibits hepatitis B virus replication in vivo J. Exp. Med. 7 2000 921 930
-
(2000)
J. Exp. Med.
, vol.7
, pp. 921-930
-
-
Kakimi, K.1
Guidotti, L.G.2
Koezuka, Y.3
Chisari, F.V.4
-
48
-
-
84946076459
-
Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B
-
S.B. Kim, S.U. Kim, B.K. Kim, J.Y. Park, D.Y. Kim, S.H. Ahn, and K.H. Han Outcome of adefovir add-on lamivudine rescue therapy of up to 5 years in patients with lamivudine-resistant chronic hepatitis B J. Gastroenterol. Hepatol. 2015
-
(2015)
J. Gastroenterol. Hepatol.
-
-
Kim, S.B.1
Kim, S.U.2
Kim, B.K.3
Park, J.Y.4
Kim, D.Y.5
Ahn, S.H.6
Han, K.H.7
-
49
-
-
84884227487
-
A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus
-
S. Koh, N. Shimasaki, R. Suwanarusk, Z.Z. Ho, A. Chia, N. Banu, S.W. Howland, A.S. Ong, A.J. Gehring, H. Stauss, L. Renia, M. Sallberg, D. Campana, and A. Bertoletti A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus Mol. Ther. Nucl. Acids 2013 e114
-
(2013)
Mol. Ther. Nucl. Acids
, pp. e114
-
-
Koh, S.1
Shimasaki, N.2
Suwanarusk, R.3
Ho, Z.Z.4
Chia, A.5
Banu, N.6
Howland, S.W.7
Ong, A.S.8
Gehring, A.J.9
Stauss, H.10
Renia, L.11
Sallberg, M.12
Campana, D.13
Bertoletti, A.14
-
50
-
-
84866169967
-
DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model
-
A.D. Kosinska, L. Johrden, E. Zhang, M. Fiedler, A. Mayer, O. Wildner, M. Lu, and M. Roggendorf DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model J. Virol. 17 2012 9297 9310
-
(2012)
J. Virol.
, vol.17
, pp. 9297-9310
-
-
Kosinska, A.D.1
Johrden, L.2
Zhang, E.3
Fiedler, M.4
Mayer, A.5
Wildner, O.6
Lu, M.7
Roggendorf, M.8
-
51
-
-
84879549459
-
Combination of DNA prime-adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model
-
A.D. Kosinska, E. Zhang, L. Johrden, J. Liu, P.L. Seiz, X. Zhang, Z. Ma, T. Kemper, M. Fiedler, D. Glebe, O. Wildner, U. Dittmer, M. Lu, and M. Roggendorf Combination of DNA prime-adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model PLoS Pathog. 6 2013 e1003391
-
(2013)
PLoS Pathog.
, vol.6
, pp. e1003391
-
-
Kosinska, A.D.1
Zhang, E.2
Johrden, L.3
Liu, J.4
Seiz, P.L.5
Zhang, X.6
Ma, Z.7
Kemper, T.8
Fiedler, M.9
Glebe, D.10
Wildner, O.11
Dittmer, U.12
Lu, M.13
Roggendorf, M.14
-
52
-
-
84880582625
-
T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice
-
K. Krebs, N. Bottinger, L.R. Huang, M. Chmielewski, S. Arzberger, G. Gasteiger, C. Jager, E. Schmitt, F. Bohne, M. Aichler, W. Uckert, H. Abken, M. Heikenwalder, P. Knolle, and U. Protzer T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice Gastroenterology 2 2013 456 465
-
(2013)
Gastroenterology
, vol.2
, pp. 456-465
-
-
Krebs, K.1
Bottinger, N.2
Huang, L.R.3
Chmielewski, M.4
Arzberger, S.5
Gasteiger, G.6
Jager, C.7
Schmitt, E.8
Bohne, F.9
Aichler, M.10
Uckert, W.11
Abken, H.12
Heikenwalder, M.13
Knolle, P.14
Protzer, U.15
-
53
-
-
84907190276
-
Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction
-
P.D. Kurktschiev, B. Raziorrouh, W. Schraut, M. Backmund, M. Wachtler, C.M. Wendtner, B. Bengsch, R. Thimme, G. Denk, R. Zachoval, A. Dick, M. Spannagl, J. Haas, H.M. Diepolder, M.C. Jung, and N.H. Gruener Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction J. Exp. Med. 10 2014 2047 2059
-
(2014)
J. Exp. Med.
, vol.10
, pp. 2047-2059
-
-
Kurktschiev, P.D.1
Raziorrouh, B.2
Schraut, W.3
Backmund, M.4
Wachtler, M.5
Wendtner, C.M.6
Bengsch, B.7
Thimme, R.8
Denk, G.9
Zachoval, R.10
Dick, A.11
Spannagl, M.12
Haas, J.13
Diepolder, H.M.14
Jung, M.C.15
Gruener, N.H.16
-
54
-
-
84879601220
-
Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance
-
P. Lan, C. Zhang, Q. Han, J. Zhang, and Z. Tian Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance Hepatology 1 2013 73 85
-
(2013)
Hepatology
, vol.1
, pp. 73-85
-
-
Lan, P.1
Zhang, C.2
Han, Q.3
Zhang, J.4
Tian, Z.5
-
55
-
-
84878276077
-
GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees
-
R.E. Lanford, B. Guerra, D. Chavez, L. Giavedoni, V.L. Hodara, K.M. Brasky, A. Fosdick, C.R. Frey, J. Zheng, G. Wolfgang, R.L. Halcomb, and D.B. Tumas GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees Gastroenterology 7 1508-1517 2013 1511 1517
-
(2013)
Gastroenterology
, vol.7
, Issue.1508-1517
, pp. 1511-1517
-
-
Lanford, R.E.1
Guerra, B.2
Chavez, D.3
Giavedoni, L.4
Hodara, V.L.5
Brasky, K.M.6
Fosdick, A.7
Frey, C.R.8
Zheng, J.9
Wolfgang, G.10
Halcomb, R.L.11
Tumas, D.B.12
-
56
-
-
21244447705
-
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
-
G.K. Lau, T. Piratvisuth, K.X. Luo, P. Marcellin, S. Thongsawat, G. Cooksley, E. Gane, M.W. Fried, W.C. Chow, S.W. Paik, W.Y. Chang, T. Berg, R. Flisiak, P. McCloud, and N. Pluck Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B N. Engl. J. Med. 26 2005 2682 2695
-
(2005)
N. Engl. J. Med.
, vol.26
, pp. 2682-2695
-
-
Lau, G.K.1
Piratvisuth, T.2
Luo, K.X.3
Marcellin, P.4
Thongsawat, S.5
Cooksley, G.6
Gane, E.7
Fried, M.W.8
Chow, W.C.9
Paik, S.W.10
Chang, W.Y.11
Berg, T.12
Flisiak, R.13
McCloud, P.14
Pluck, N.15
-
57
-
-
84879315928
-
Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice
-
F. Li, H. Wei, H. Wei, Y. Gao, L. Xu, W. Yin, R. Sun, and Z. Tian Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice Gastroenterology 2 2013 392 401
-
(2013)
Gastroenterology
, vol.2
, pp. 392-401
-
-
Li, F.1
Wei, H.2
Wei, H.3
Gao, Y.4
Xu, L.5
Yin, W.6
Sun, R.7
Tian, Z.8
-
58
-
-
84895773844
-
Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B
-
Y. Li, J.J. Wang, S. Gao, Q. Liu, J. Bai, X.Q. Zhao, Y.H. Hao, H.H. Ding, F. Zhu, D.L. Yang, and X.P. Zhao Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B PLoS One 2 2014 e86927
-
(2014)
PLoS One
, vol.2
, pp. e86927
-
-
Li, Y.1
Wang, J.J.2
Gao, S.3
Liu, Q.4
Bai, J.5
Zhao, X.Q.6
Hao, Y.H.7
Ding, H.H.8
Zhu, F.9
Yang, D.L.10
Zhao, X.P.11
-
59
-
-
84922756184
-
Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B
-
J. Li, M. Jia, Y. Liu, W. She, L. Li, J. Wang, and W. Jiang Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B Liver Int. 3 2015 834 845
-
(2015)
Liver Int.
, vol.3
, pp. 834-845
-
-
Li, J.1
Jia, M.2
Liu, Y.3
She, W.4
Li, L.5
Wang, J.6
Jiang, W.7
-
60
-
-
84968842075
-
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: Results of a randomised trial
-
Y.S. Lim, B.C. Yoo, K.S. Byun, S.Y. Kwon, Y.J. Kim, J. An, H.C. Lee, and Y.S. Lee Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial Gut 2015
-
(2015)
Gut
-
-
Lim, Y.S.1
Yoo, B.C.2
Byun, K.S.3
Kwon, S.Y.4
Kim, Y.J.5
An, J.6
Lee, H.C.7
Lee, Y.S.8
-
61
-
-
84907379292
-
The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo
-
S.R. Lin, H.C. Yang, Y.T. Kuo, C.J. Liu, T.Y. Yang, K.C. Sung, Y.Y. Lin, H.Y. Wang, C.C. Wang, Y.C. Shen, F.Y. Wu, J.H. Kao, D.S. Chen, and P.J. Chen The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo Mol. Ther. Nucl. Acids 2014 e186
-
(2014)
Mol. Ther. Nucl. Acids
, pp. e186
-
-
Lin, S.R.1
Yang, H.C.2
Kuo, Y.T.3
Liu, C.J.4
Yang, T.Y.5
Sung, K.C.6
Lin, Y.Y.7
Wang, H.Y.8
Wang, C.C.9
Shen, Y.C.10
Wu, F.Y.11
Kao, J.H.12
Chen, D.S.13
Chen, P.J.14
-
62
-
-
84893805242
-
Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection
-
J. Liu, E. Zhang, Z. Ma, W. Wu, A. Kosinska, X. Zhang, I. Moller, P. Seiz, D. Glebe, B. Wang, D. Yang, M. Lu, and M. Roggendorf Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection PLoS Pathog. 1 2014 e1003856
-
(2014)
PLoS Pathog.
, vol.1
, pp. e1003856
-
-
Liu, J.1
Zhang, E.2
Ma, Z.3
Wu, W.4
Kosinska, A.5
Zhang, X.6
Moller, I.7
Seiz, P.8
Glebe, D.9
Wang, B.10
Yang, D.11
Lu, M.12
Roggendorf, M.13
-
63
-
-
30344458192
-
Cellular and virological mechanisms of HBV drug resistance
-
S. Locarnini, and W.S. Mason Cellular and virological mechanisms of HBV drug resistance J. Hepatol. 2 2006 422 431
-
(2006)
J. Hepatol.
, vol.2
, pp. 422-431
-
-
Locarnini, S.1
Mason, W.S.2
-
64
-
-
39749112519
-
Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model
-
M. Lu, X. Yao, Y. Xu, H. Lorenz, U. Dahmen, H. Chi, O. Dirsch, T. Kemper, L. He, D. Glebe, W.H. Gerlich, Y. Wen, and M. Roggendorf Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model J. Virol. 5 2008 2598 2603
-
(2008)
J. Virol.
, vol.5
, pp. 2598-2603
-
-
Lu, M.1
Yao, X.2
Xu, Y.3
Lorenz, H.4
Dahmen, U.5
Chi, H.6
Dirsch, O.7
Kemper, T.8
He, L.9
Glebe, D.10
Gerlich, W.H.11
Wen, Y.12
Roggendorf, M.13
-
65
-
-
84896029673
-
Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA
-
J. Lucifora, Y. Xia, F. Reisinger, K. Zhang, D. Stadler, X. Cheng, M.F. Sprinzl, H. Koppensteiner, Z. Makowska, T. Volz, C. Remouchamps, W.M. Chou, W.E. Thasler, N. Huser, D. Durantel, T.J. Liang, C. Munk, M.H. Heim, J.L. Browning, E. Dejardin, M. Dandri, M. Schindler, M. Heikenwalder, and U. Protzer Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA Science 6176 2014 1221 1228
-
(2014)
Science
, vol.6176
, pp. 1221-1228
-
-
Lucifora, J.1
Xia, Y.2
Reisinger, F.3
Zhang, K.4
Stadler, D.5
Cheng, X.6
Sprinzl, M.F.7
Koppensteiner, H.8
Makowska, Z.9
Volz, T.10
Remouchamps, C.11
Chou, W.M.12
Thasler, W.E.13
Huser, N.14
Durantel, D.15
Liang, T.J.16
Munk, C.17
Heim, M.H.18
Browning, J.L.19
Dejardin, E.20
Dandri, M.21
Schindler, M.22
Heikenwalder, M.23
Protzer, U.24
more..
-
66
-
-
84928888455
-
Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses
-
Z. Ma, E. Zhang, D. Yang, and M. Lu Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses Cell Mol. Immunol. 3 2015 273 282
-
(2015)
Cell Mol. Immunol.
, vol.3
, pp. 273-282
-
-
Ma, Z.1
Zhang, E.2
Yang, D.3
Lu, M.4
-
67
-
-
84883746075
-
NK cells: A double-edged sword in chronic hepatitis B virus infection
-
M.K. Maini, and D. Peppa NK cells: a double-edged sword in chronic hepatitis B virus infection Front. Immunol. 2013 57
-
(2013)
Front. Immunol.
, pp. 57
-
-
Maini, M.K.1
Peppa, D.2
-
68
-
-
84939805890
-
Nivolumab in the treatment of malignant melanoma: Review of the literature
-
E. Mashima, A. Inoue, Y. Sakuragi, T. Yamaguchi, N. Sasaki, Y. Hara, D. Omoto, S. Ohmori, S. Haruyama, Y. Sawada, M. Yoshioka, D. Nishio, and M. Nakamura Nivolumab in the treatment of malignant melanoma: review of the literature Onco Targets Ther. 2015 2045 2051
-
(2015)
Onco Targets Ther.
, pp. 2045-2051
-
-
Mashima, E.1
Inoue, A.2
Sakuragi, Y.3
Yamaguchi, T.4
Sasaki, N.5
Hara, Y.6
Omoto, D.7
Ohmori, S.8
Haruyama, S.9
Sawada, Y.10
Yoshioka, M.11
Nishio, D.12
Nakamura, M.13
-
69
-
-
81355129949
-
1114 anti-viral efficacy and induction of an antibody response against surface antigen with the TLR7 agonist GS-9620 in the woodchuck model of chronic HBV infection
-
S. Menne, B.C. Tennant, K.H. Liu, M.A. Ascenzi, B.H. Baldwin, C.A. Bellezza, P.J. Cote, X. Zheng, G. Wolfgang, and D. Turnas 1114 anti-viral efficacy and induction of an antibody response against surface antigen with the TLR7 agonist GS-9620 in the woodchuck model of chronic HBV infection J. Hepatol. 2011 S441
-
(2011)
J. Hepatol.
, pp. S441
-
-
Menne, S.1
Tennant, B.C.2
Liu, K.H.3
Ascenzi, M.A.4
Baldwin, B.H.5
Bellezza, C.A.6
Cote, P.J.7
Zheng, X.8
Wolfgang, G.9
Turnas, D.10
-
70
-
-
84929606985
-
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
-
S. Menne, D.B. Tumas, K.H. Liu, L. Thampi, D. AlDeghaither, B.H. Baldwin, C.A. Bellezza, P.J. Cote, J. Zheng, R. Halcomb, A. Fosdick, S.P. Fletcher, S. Daffis, L. Li, P. Yue, G.H. Wolfgang, and B.C. Tennant Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B J. Hepatol. 6 2015 1237 1245
-
(2015)
J. Hepatol.
, vol.6
, pp. 1237-1245
-
-
Menne, S.1
Tumas, D.B.2
Liu, K.H.3
Thampi, L.4
AlDeghaither, D.5
Baldwin, B.H.6
Bellezza, C.A.7
Cote, P.J.8
Zheng, J.9
Halcomb, R.10
Fosdick, A.11
Fletcher, S.P.12
Daffis, S.13
Li, L.14
Yue, P.15
Wolfgang, G.H.16
Tennant, B.C.17
-
71
-
-
40849083509
-
Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection
-
D.S. Miller, D. Boyle, F. Feng, G.Y. Reaiche, I. Kotlarski, R. Colonno, and A.R. Jilbert Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection Virology 2 2008 329 341
-
(2008)
Virology
, vol.2
, pp. 329-341
-
-
Miller, D.S.1
Boyle, D.2
Feng, F.3
Reaiche, G.Y.4
Kotlarski, I.5
Colonno, R.6
Jilbert, A.R.7
-
72
-
-
0028270410
-
MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice
-
D. Moskophidis, F. Lechner, H. Hengartner, and R.M. Zinkernagel MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice J. Immunol. 10 1994 4976 4983
-
(1994)
J. Immunol.
, vol.10
, pp. 4976-4983
-
-
Moskophidis, D.1
Lechner, F.2
Hengartner, H.3
Zinkernagel, R.M.4
-
73
-
-
84868159278
-
Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection
-
G. Nebbia, D. Peppa, A. Schurich, P. Khanna, H.D. Singh, Y. Cheng, W. Rosenberg, G. Dusheiko, R. Gilson, J. ChinAleong, P. Kennedy, and M.K. Maini Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection PLoS One 10 2012 e47648
-
(2012)
PLoS One
, vol.10
, pp. e47648
-
-
Nebbia, G.1
Peppa, D.2
Schurich, A.3
Khanna, P.4
Singh, H.D.5
Cheng, Y.6
Rosenberg, W.7
Dusheiko, G.8
Gilson, R.9
ChinAleong, J.10
Kennedy, P.11
Maini, M.K.12
-
74
-
-
84885929771
-
Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro
-
F. Noordeen, A. Vaillant, and A.R. Jilbert Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro Antimicrob. Agents Chemother. 11 2013 5291 5298
-
(2013)
Antimicrob. Agents Chemother.
, vol.11
, pp. 5291-5298
-
-
Noordeen, F.1
Vaillant, A.2
Jilbert, A.R.3
-
75
-
-
80054972200
-
Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope
-
H.L. Oh, A. Chia, C.X. Chang, H.N. Leong, K.L. Ling, G.M. Grotenbreg, A.J. Gehring, Y.J. Tan, and A. Bertoletti Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope J. Virol. 20 2011 10464 10471
-
(2011)
J. Virol.
, vol.20
, pp. 10464-10471
-
-
Oh, H.L.1
Chia, A.2
Chang, C.X.3
Leong, H.N.4
Ling, K.L.5
Grotenbreg, G.M.6
Gehring, A.J.7
Tan, Y.J.8
Bertoletti, A.9
-
76
-
-
84864359147
-
Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B
-
I. Otano, L. Suarez, J. Dotor, M. Gonzalez-Aparicio, J. Crettaz, C. Olague, A. Vales, J.I. Riezu, E. Larrea, F. Borras, A. Benito, R. Hernandez-Alcoceba, S. Menne, J. Prieto, and G. Gonzalez-Aseguinolaza Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B Hepatology 2 2012 474 483
-
(2012)
Hepatology
, vol.2
, pp. 474-483
-
-
Otano, I.1
Suarez, L.2
Dotor, J.3
Gonzalez-Aparicio, M.4
Crettaz, J.5
Olague, C.6
Vales, A.7
Riezu, J.I.8
Larrea, E.9
Borras, F.10
Benito, A.11
Hernandez-Alcoceba, R.12
Menne, S.13
Prieto, J.14
Gonzalez-Aseguinolaza, G.15
-
77
-
-
84857358267
-
Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
-
J.J. Ott, G.A. Stevens, J. Groeger, and S.T. Wiersma Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 12 2012 2212 2219
-
(2012)
Vaccine
, vol.12
, pp. 2212-2219
-
-
Ott, J.J.1
Stevens, G.A.2
Groeger, J.3
Wiersma, S.T.4
-
78
-
-
0032191962
-
Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection
-
A. Oxenius, R.M. Zinkernagel, and H. Hengartner Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection Immunity 4 1998 449 457
-
(1998)
Immunity
, vol.4
, pp. 449-457
-
-
Oxenius, A.1
Zinkernagel, R.M.2
Hengartner, H.3
-
79
-
-
84867912743
-
TCR-redirected human T cells inhibit hepatitis C virus replication: Hepatotoxic potential is linked to antigen specificity and functional avidity
-
A. Pasetto, L. Frelin, S. Aleman, F. Holmstrom, A. Brass, G. Ahlen, E.D. Brenndorfer, V. Lohmann, R. Bartenschlager, M. Sallberg, A. Bertoletti, and M. Chen TCR-redirected human T cells inhibit hepatitis C virus replication: hepatotoxic potential is linked to antigen specificity and functional avidity J. Immunol. 9 2012 4510 4519
-
(2012)
J. Immunol.
, vol.9
, pp. 4510-4519
-
-
Pasetto, A.1
Frelin, L.2
Aleman, S.3
Holmstrom, F.4
Brass, A.5
Ahlen, G.6
Brenndorfer, E.D.7
Lohmann, V.8
Bartenschlager, R.9
Sallberg, M.10
Bertoletti, A.11
Chen, M.12
-
80
-
-
9544232506
-
Long-lasting memory T cell responses following self-limited acute hepatitis B
-
A. Penna, M. Artini, A. Cavalli, M. Levrero, A. Bertoletti, M. Pilli, F.V. Chisari, B. Rehermann, P.G. Del, F. Fiaccadori, and C. Ferrari Long-lasting memory T cell responses following self-limited acute hepatitis B J. Clin. Invest. 5 1996 1185 1194
-
(1996)
J. Clin. Invest.
, vol.5
, pp. 1185-1194
-
-
Penna, A.1
Artini, M.2
Cavalli, A.3
Levrero, M.4
Bertoletti, A.5
Pilli, M.6
Chisari, F.V.7
Rehermann, B.8
Del, P.G.9
Fiaccadori, F.10
Ferrari, C.11
-
81
-
-
78651225310
-
Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection
-
D. Peppa, L. Micco, A. Javaid, P.T. Kennedy, A. Schurich, C. Dunn, C. Pallant, G. Ellis, P. Khanna, G. Dusheiko, R.J. Gilson, and M.K. Maini Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection PLoS Pathog. 12 2010 e1001227
-
(2010)
PLoS Pathog.
, vol.12
, pp. e1001227
-
-
Peppa, D.1
Micco, L.2
Javaid, A.3
Kennedy, P.T.4
Schurich, A.5
Dunn, C.6
Pallant, C.7
Ellis, G.8
Khanna, P.9
Dusheiko, G.10
Gilson, R.J.11
Maini, M.K.12
-
82
-
-
84874543706
-
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion
-
D. Peppa, U.S. Gill, G. Reynolds, N.J. Easom, L.J. Pallett, A. Schurich, L. Micco, G. Nebbia, H.D. Singh, D.H. Adams, P.T. Kennedy, and M.K. Maini Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion J. Exp. Med. 1 2013 99 114
-
(2013)
J. Exp. Med.
, vol.1
, pp. 99-114
-
-
Peppa, D.1
Gill, U.S.2
Reynolds, G.3
Easom, N.J.4
Pallett, L.J.5
Schurich, A.6
Micco, L.7
Nebbia, G.8
Singh, H.D.9
Adams, D.H.10
Kennedy, P.T.11
Maini, M.K.12
-
83
-
-
0017150602
-
Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer
-
R.H. Purcell, W.T. London, V.J. McAuliffe, A.E. Palmer, P.M. Kaplan, J.L. Gerin, J. Wagner, H. Popper, E. Lvovsky, D.C. Wong, and H.B. Levy Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer Lancet 7989 1976 757 761
-
(1976)
Lancet
, vol.7989
, pp. 757-761
-
-
Purcell, R.H.1
London, W.T.2
McAuliffe, V.J.3
Palmer, A.E.4
Kaplan, P.M.5
Gerin, J.L.6
Wagner, J.7
Popper, H.8
Lvovsky, E.9
Wong, D.C.10
Levy, H.B.11
-
84
-
-
84922268964
-
Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
-
W. Qasim, M. Brunetto, A.J. Gehring, S.A. Xue, A. Schurich, A. Khakpoor, H. Zhan, P. Ciccorossi, K. Gilmour, D. Cavallone, F. Moriconi, F. Farzhenah, A. Mazzoni, L. Chan, E. Morris, A. Thrasher, M.K. Maini, F. Bonino, H. Stauss, and A. Bertoletti Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient J. Hepatol. 2 2015 486 491
-
(2015)
J. Hepatol.
, vol.2
, pp. 486-491
-
-
Qasim, W.1
Brunetto, M.2
Gehring, A.J.3
Xue, S.A.4
Schurich, A.5
Khakpoor, A.6
Zhan, H.7
Ciccorossi, P.8
Gilmour, K.9
Cavallone, D.10
Moriconi, F.11
Farzhenah, F.12
Mazzoni, A.13
Chan, L.14
Morris, E.15
Thrasher, A.16
Maini, M.K.17
Bonino, F.18
Stauss, H.19
Bertoletti, A.20
more..
-
85
-
-
78649625973
-
The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function
-
B. Raziorrouh, W. Schraut, T. Gerlach, D. Nowack, N.H. Gruner, A. Ulsenheimer, R. Zachoval, M. Wachtler, M. Spannagl, J. Haas, H.M. Diepolder, and M.C. Jung The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function Hepatology 6 2010 1934 1947
-
(2010)
Hepatology
, vol.6
, pp. 1934-1947
-
-
Raziorrouh, B.1
Schraut, W.2
Gerlach, T.3
Nowack, D.4
Gruner, N.H.5
Ulsenheimer, A.6
Zachoval, R.7
Wachtler, M.8
Spannagl, M.9
Haas, J.10
Diepolder, H.M.11
Jung, M.C.12
-
86
-
-
84880276248
-
Pathogenesis of chronic viral hepatitis: Differential roles of T cells and NK cells
-
B. Rehermann Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells Nat. Med. 7 2013 859 868
-
(2013)
Nat. Med.
, vol.7
, pp. 859-868
-
-
Rehermann, B.1
-
87
-
-
0029838758
-
The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response
-
B. Rehermann, C. Ferrari, C. Pasquinelli, and F.V. Chisari The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response Nat. Med. 10 1996 1104 1108
-
(1996)
Nat. Med.
, vol.10
, pp. 1104-1108
-
-
Rehermann, B.1
Ferrari, C.2
Pasquinelli, C.3
Chisari, F.V.4
-
88
-
-
0030008076
-
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
-
B. Rehermann, D. Lau, J.H. Hoofnagle, and F.V. Chisari Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection J. Clin. Invest. 7 1996 1655 1665
-
(1996)
J. Clin. Invest.
, vol.7
, pp. 1655-1665
-
-
Rehermann, B.1
Lau, D.2
Hoofnagle, J.H.3
Chisari, F.V.4
-
89
-
-
84942163394
-
Virus-Like vesicle-based therapeutic vaccine vectors for chronic hepatitis B virus infection
-
T.D. Reynolds, L. Buonocore, N.F. Rose, J.K. Rose, and M.D. Robek Virus-Like vesicle-based therapeutic vaccine vectors for chronic hepatitis B virus infection J. Virol. 2015
-
(2015)
J. Virol.
-
-
Reynolds, T.D.1
Buonocore, L.2
Rose, N.F.3
Rose, J.K.4
Robek, M.D.5
-
90
-
-
30944449094
-
Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity
-
E.I. Rigopoulou, D. Suri, S. Chokshi, I. Mullerova, S. Rice, R.S. Tedder, R. Williams, and N.V. Naoumov Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity Hepatology 5 2005 1028 1036
-
(2005)
Hepatology
, vol.5
, pp. 1028-1036
-
-
Rigopoulou, E.I.1
Suri, D.2
Chokshi, S.3
Mullerova, I.4
Rice, S.5
Tedder, R.S.6
Williams, R.7
Naoumov, N.V.8
-
91
-
-
0016206027
-
DNA polymerase in the core of the human hepatitis B virus candidate
-
W.S. Robinson, and R.L. Greenman DNA polymerase in the core of the human hepatitis B virus candidate J. Virol. 6 1974 1231 1236
-
(1974)
J. Virol.
, vol.6
, pp. 1231-1236
-
-
Robinson, W.S.1
Greenman, R.L.2
-
92
-
-
70450193052
-
Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma
-
J.R. Rodriguez-Madoz, K.H. Liu, J.I. Quetglas, M. Ruiz-Guillen, I. Otano, J. Crettaz, S.D. Butler, C.A. Bellezza, N.L. Dykes, B.C. Tennant, J. Prieto, G. Gonzalez-Aseguinolaza, C. Smerdou, and S. Menne Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma J. Virol. 23 2009 12266 12278
-
(2009)
J. Virol.
, vol.23
, pp. 12266-12278
-
-
Rodriguez-Madoz, J.R.1
Liu, K.H.2
Quetglas, J.I.3
Ruiz-Guillen, M.4
Otano, I.5
Crettaz, J.6
Butler, S.D.7
Bellezza, C.A.8
Dykes, N.L.9
Tennant, B.C.10
Prieto, J.11
Gonzalez-Aseguinolaza, G.12
Smerdou, C.13
Menne, S.14
-
93
-
-
77955430666
-
The woodchuck: A model for therapeutic vaccination against hepadnaviral infection
-
M. Roggendorf, D. Yang, and M. Lu The woodchuck: a model for therapeutic vaccination against hepadnaviral infection Pathol. Biol. (Paris) 4 2010 308 314
-
(2010)
Pathol. Biol. (Paris)
, vol.4
, pp. 308-314
-
-
Roggendorf, M.1
Yang, D.2
Lu, M.3
-
94
-
-
0030959049
-
Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
-
S. Rossol, G. Marinos, P. Carucci, M.V. Singer, R. Williams, and N.V. Naoumov Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B J. Clin. Invest. 12 1997 3025 3033
-
(1997)
J. Clin. Invest.
, vol.12
, pp. 3025-3033
-
-
Rossol, S.1
Marinos, G.2
Carucci, P.3
Singer, M.V.4
Williams, R.5
Naoumov, N.V.6
-
95
-
-
79955112364
-
Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection
-
A. Schurich, P. Khanna, A.R. Lopes, K.J. Han, D. Peppa, L. Micco, G. Nebbia, P.T. Kennedy, A.M. Geretti, G. Dusheiko, and M.K. Maini Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection Hepatology 5 2011 1494 1503
-
(2011)
Hepatology
, vol.5
, pp. 1494-1503
-
-
Schurich, A.1
Khanna, P.2
Lopes, A.R.3
Han, K.J.4
Peppa, D.5
Micco, L.6
Nebbia, G.7
Kennedy, P.T.8
Geretti, A.M.9
Dusheiko, G.10
Maini, M.K.11
-
96
-
-
84875996342
-
The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells
-
A. Schurich, L.J. Pallett, M. Lubowiecki, H.D. Singh, U.S. Gill, P.T. Kennedy, E. Nastouli, S. Tanwar, W. Rosenberg, and M.K. Maini The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells PLoS Pathog. 3 2013 e1003208
-
(2013)
PLoS Pathog.
, vol.3
, pp. e1003208
-
-
Schurich, A.1
Pallett, L.J.2
Lubowiecki, M.3
Singh, H.D.4
Gill, U.S.5
Kennedy, P.T.6
Nastouli, E.7
Tanwar, S.8
Rosenberg, W.9
Maini, M.K.10
-
97
-
-
0025183686
-
Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts
-
M. Seifer, K.H. Heermann, and W.H. Gerlich Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts Virology 1 1990 287 299
-
(1990)
Virology
, vol.1
, pp. 287-299
-
-
Seifer, M.1
Heermann, K.H.2
Gerlich, W.H.3
-
98
-
-
58949094406
-
Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice
-
B. Serruys, F. Van Houtte, P. Verbrugghe, G. Leroux-Roels, and P. Vanlandschoot Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice Hepatology 1 2009 39 49
-
(2009)
Hepatology
, vol.1
, pp. 39-49
-
-
Serruys, B.1
Van Houtte, F.2
Verbrugghe, P.3
Leroux-Roels, G.4
Vanlandschoot, P.5
-
99
-
-
84916219853
-
Lymphotoxin beta receptor activation promotes bladder cancer in a nuclear factor-kappaB-dependent manner
-
M. Shen, X. Duan, P. Zhou, W. Zhou, X. Wu, S. Xu, Y. Chen, and Z. Tao Lymphotoxin beta receptor activation promotes bladder cancer in a nuclear factor-kappaB-dependent manner Mol. Med. Rep. 2 2015 783 790
-
(2015)
Mol. Med. Rep.
, vol.2
, pp. 783-790
-
-
Shen, M.1
Duan, X.2
Zhou, P.3
Zhou, W.4
Wu, X.5
Xu, S.6
Chen, Y.7
Tao, Z.8
-
100
-
-
84922362557
-
Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B
-
M. Shi, W.L. Sun, Y.Y. Hua, B. Han, and L. Shi Effects of entecavir on hepatitis B virus covalently closed circular DNA in hepatitis B e antigen-positive patients with hepatitis B PLoS One 2 2015 e117741
-
(2015)
PLoS One
, vol.2
, pp. e117741
-
-
Shi, M.1
Sun, W.L.2
Hua, Y.Y.3
Han, B.4
Shi, L.5
-
101
-
-
84902967486
-
Opening fronts in HIV vaccine development: Targeting reservoirs to clear and cure
-
R.F. Siliciano Opening fronts in HIV vaccine development: targeting reservoirs to clear and cure Nat. Med. 5 2014 480 481
-
(2014)
Nat. Med.
, vol.5
, pp. 480-481
-
-
Siliciano, R.F.1
-
102
-
-
84903615913
-
Recent developments in the search for a cure for HIV-1 infection: Targeting the latent reservoir for HIV-1
-
J.D. Siliciano, and R.F. Siliciano Recent developments in the search for a cure for HIV-1 infection: targeting the latent reservoir for HIV-1 J. Allergy Clin. Immunol. 1 2014 12 19
-
(2014)
J. Allergy Clin. Immunol.
, vol.1
, pp. 12-19
-
-
Siliciano, J.D.1
Siliciano, R.F.2
-
103
-
-
84943383941
-
Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment with pegylated interferon alfa-2a and adefovir
-
F. Stelma, A. de Niet, P.M. Tempelmans, L. Jansen, R.B. Takkenberg, H.W. Reesink, N.A. Kootstra, and E.M. van Leeuwen Natural killer cell characteristics in patients with chronic hepatitis B virus (HBV) infection are associated with HBV surface antigen clearance after combination treatment with pegylated interferon alfa-2a and adefovir J. Infect. Dis. 2015
-
(2015)
J. Infect. Dis.
-
-
Stelma, F.1
De Niet, A.2
Tempelmans, P.M.3
Jansen, L.4
Takkenberg, R.B.5
Reesink, H.W.6
Kootstra, N.A.7
Van Leeuwen, E.M.8
-
104
-
-
0020526688
-
Structural relationships between minor and major proteins of hepatitis B surface antigen
-
W. Stibbe, and W.H. Gerlich Structural relationships between minor and major proteins of hepatitis B surface antigen J. Virol. 2 1983 626 628
-
(1983)
J. Virol.
, vol.2
, pp. 626-628
-
-
Stibbe, W.1
Gerlich, W.H.2
-
105
-
-
33845868485
-
BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly
-
S.J. Stray, and A. Zlotnick BAY 41-4109 has multiple effects on hepatitis B virus capsid assembly J. Mol. Recognit. 6 2006 542 548
-
(2006)
J. Mol. Recognit.
, vol.6
, pp. 542-548
-
-
Stray, S.J.1
Zlotnick, A.2
-
106
-
-
84937072813
-
Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B
-
F. Su, J. Dai, S. Yang, X. Jiang, X. Cui, H. Ning, J. Li, and M. Huang Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B J. Med. Virol. 9 2015 1527 1531
-
(2015)
J. Med. Virol.
, vol.9
, pp. 1527-1531
-
-
Su, F.1
Dai, J.2
Yang, S.3
Jiang, X.4
Cui, X.5
Ning, H.6
Li, J.7
Huang, M.8
-
107
-
-
0019949367
-
Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate
-
J. Summers, and W.S. Mason Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate Cell 2 1982 403 415
-
(1982)
Cell
, vol.2
, pp. 403-415
-
-
Summers, J.1
Mason, W.S.2
-
108
-
-
84928887199
-
NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
-
C. Sun, H. Sun, C. Zhang, and Z. Tian NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma Cell Mol. Immunol. 3 2015 292 302
-
(2015)
Cell Mol. Immunol.
, vol.3
, pp. 292-302
-
-
Sun, C.1
Sun, H.2
Zhang, C.3
Tian, Z.4
-
109
-
-
74449084299
-
Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine
-
M. Surquin, C.L. Tielemans, I. Kulcsar, M. Ryba, P. Voros, O. Mat, S. Treille, M. Dhaene, J.C. Stolear, S.O. Kuriyakose, M.X. Leyssen, and S.A. Houard Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-adjuvanted hepatitis B vaccine Kidney Int. 3 2010 247 255
-
(2010)
Kidney Int.
, vol.3
, pp. 247-255
-
-
Surquin, M.1
Tielemans, C.L.2
Kulcsar, I.3
Ryba, M.4
Voros, P.5
Mat, O.6
Treille, S.7
Dhaene, M.8
Stolear, J.C.9
Kuriyakose, S.O.10
Leyssen, M.X.11
Houard, S.A.12
-
110
-
-
15244343352
-
Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection
-
A. Szkaradkiewicz, A. Jopek, and J. Wysocki Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection Antiviral Res. 1 2005 23 27
-
(2005)
Antiviral Res.
, vol.1
, pp. 23-27
-
-
Szkaradkiewicz, A.1
Jopek, A.2
Wysocki, J.3
-
111
-
-
84889803644
-
A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity
-
W. Tan, Y. Meng, H. Li, Y. Chen, S. Han, J. Zeng, A. Huang, B. Li, Y. Zhang, and Y. Guo A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity mAbs-Austin 6 2013 946 955
-
(2013)
MAbs-Austin
, vol.6
, pp. 946-955
-
-
Tan, W.1
Meng, Y.2
Li, H.3
Chen, Y.4
Han, S.5
Zeng, J.6
Huang, A.7
Li, B.8
Zhang, Y.9
Guo, Y.10
-
112
-
-
84927950089
-
The hepatitis B virus ribonuclease H as a drug target
-
J.E. Tavis, and E. Lomonosova The hepatitis B virus ribonuclease H as a drug target Antiviral Res. 2015 132 138
-
(2015)
Antiviral Res.
, pp. 132-138
-
-
Tavis, J.E.1
Lomonosova, E.2
-
113
-
-
84893716133
-
Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B
-
E.T. Tjwa, R. Zoutendijk, G.W. van Oord, P.J. Biesta, J. Verheij, H.L. Janssen, A.M. Woltman, and A. Boonstra Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B Liver Int. 3 2014 396 404
-
(2014)
Liver Int.
, vol.3
, pp. 396-404
-
-
Tjwa, E.T.1
Zoutendijk, R.2
Van Oord, G.W.3
Biesta, P.J.4
Verheij, J.5
Janssen, H.L.6
Woltman, A.M.7
Boonstra, A.8
-
114
-
-
84983720423
-
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
-
H.T. Tzeng, H.F. Tsai, H.J. Liao, Y.J. Lin, L. Chen, P.J. Chen, and P.N. Hsu PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model PLoS One 6 2012 e39179
-
(2012)
PLoS One
, vol.6
, pp. e39179
-
-
Tzeng, H.T.1
Tsai, H.F.2
Liao, H.J.3
Lin, Y.J.4
Chen, L.5
Chen, P.J.6
Hsu, P.N.7
-
115
-
-
84865773658
-
In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations
-
X.Y. Wang, Z.M. Wei, G.Y. Wu, J.H. Wang, Y.J. Zhang, J. Li, H.H. Zhang, X.W. Xie, X. Wang, Z.H. Wang, L. Wei, Y. Wang, and H.S. Chen In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations Antiviral Ther. 5 2012 793 803
-
(2012)
Antiviral Ther.
, vol.5
, pp. 793-803
-
-
Wang, X.Y.1
Wei, Z.M.2
Wu, G.Y.3
Wang, J.H.4
Zhang, Y.J.5
Li, J.6
Zhang, H.H.7
Xie, X.W.8
Wang, X.9
Wang, Z.H.10
Wei, L.11
Wang, Y.12
Chen, H.S.13
-
116
-
-
84930209100
-
Delayed reduction of hepatitis B viral load and dynamics of adefovir-resistant variants during adefovir plus entecavir combination rescue therapy
-
Y. Wang, S. Liu, Y. Chen, S. Zheng, L. Zhou, F. Lu, and Z. Duan Delayed reduction of hepatitis B viral load and dynamics of adefovir-resistant variants during adefovir plus entecavir combination rescue therapy Int. J. Med. Sci. 5 2015 416 422
-
(2015)
Int. J. Med. Sci.
, vol.5
, pp. 416-422
-
-
Wang, Y.1
Liu, S.2
Chen, Y.3
Zheng, S.4
Zhou, L.5
Lu, F.6
Duan, Z.7
-
117
-
-
0019980316
-
Cloned HBV DNA causes hepatitis in chimpanzees
-
H. Will, R. Cattaneo, H.G. Koch, G. Darai, H. Schaller, H. Schellekens, P.M. van Eerd, and F. Deinhardt Cloned HBV DNA causes hepatitis in chimpanzees Nature 5885 1982 740 742
-
(1982)
Nature
, vol.5885
, pp. 740-742
-
-
Will, H.1
Cattaneo, R.2
Koch, H.G.3
Darai, G.4
Schaller, H.5
Schellekens, H.6
Van Eerd, P.M.7
Deinhardt, F.8
-
118
-
-
84880608443
-
Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency
-
D.K. Wong, W.K. Seto, J. Fung, P. Ip, F.Y. Huang, C.L. Lai, and M.F. Yuen Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency Clin. Gastroenterol. Hepatol. 8 2013 1004 1010
-
(2013)
Clin. Gastroenterol. Hepatol.
, vol.8
, pp. 1004-1010
-
-
Wong, D.K.1
Seto, W.K.2
Fung, J.3
Ip, P.4
Huang, F.Y.5
Lai, C.L.6
Yuen, M.F.7
-
119
-
-
72249119029
-
Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion
-
J.F. Wu, T.C. Wu, C.H. Chen, Y.H. Ni, H.L. Chen, H.Y. Hsu, and M.H. Chang Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion Gastroenterology 1 2010 165 172
-
(2010)
Gastroenterology
, vol.1
, pp. 165-172
-
-
Wu, J.F.1
Wu, T.C.2
Chen, C.H.3
Ni, Y.H.4
Chen, H.L.5
Hsu, H.Y.6
Chang, M.H.7
-
120
-
-
84860347302
-
Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B
-
W. Wu, Y. Shi, S. Li, Y. Zhang, Y. Liu, Y. Wu, and Z. Chen Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B Eur. J. Immunol. 5 2012 1180 1191
-
(2012)
Eur. J. Immunol.
, vol.5
, pp. 1180-1191
-
-
Wu, W.1
Shi, Y.2
Li, S.3
Zhang, Y.4
Liu, Y.5
Wu, Y.6
Chen, Z.7
-
121
-
-
84885924778
-
Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly
-
G. Wu, B. Liu, Y. Zhang, J. Li, A. Arzumanyan, M.M. Clayton, R.F. Schinazi, Z. Wang, S. Goldmann, Q. Ren, F. Zhang, and M.A. Feitelson Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly Antimicrob. Agents Chemother. 11 2013 5344 5354
-
(2013)
Antimicrob. Agents Chemother.
, vol.11
, pp. 5344-5354
-
-
Wu, G.1
Liu, B.2
Zhang, Y.3
Li, J.4
Arzumanyan, A.5
Clayton, M.M.6
Schinazi, R.F.7
Wang, Z.8
Goldmann, S.9
Ren, Q.10
Zhang, F.11
Feitelson, M.A.12
-
122
-
-
84928880469
-
Polyinosinic-polycytidylic acid treatment leads to the interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model
-
J. Wu, S. Huang, X. Zhao, M. Chen, Y. Lin, Y. Xia, C. Sun, X. Yang, J. Wang, Y. Guo, J. Song, E. Zhang, B. Wang, X. Zheng, J.F. Schlaak, M. Lu, and D. Yang Polyinosinic-polycytidylic acid treatment leads to the interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model J. Virol. 2014
-
(2014)
J. Virol.
-
-
Wu, J.1
Huang, S.2
Zhao, X.3
Chen, M.4
Lin, Y.5
Xia, Y.6
Sun, C.7
Yang, X.8
Wang, J.9
Guo, Y.10
Song, J.11
Zhang, E.12
Wang, B.13
Zheng, X.14
Schlaak, J.F.15
Lu, M.16
Yang, D.17
-
123
-
-
84938204671
-
Natural killer cells in hepatitis B virus infection
-
S.F. Wu, W.J. Wang, and Y.Q. Gao Natural killer cells in hepatitis B virus infection Braz. J. Infect. Dis. 4 2015 417 425
-
(2015)
Braz. J. Infect. Dis.
, vol.4
, pp. 417-425
-
-
Wu, S.F.1
Wang, W.J.2
Gao, Y.Q.3
-
124
-
-
33947397924
-
IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers
-
S.Q. Xiong, B.L. Lin, X. Gao, H. Tang, and C.Y. Wu IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers Int. Immunopharmacol. 5 2007 578 587
-
(2007)
Int. Immunopharmacol.
, vol.5
, pp. 578-587
-
-
Xiong, S.Q.1
Lin, B.L.2
Gao, X.3
Tang, H.4
Wu, C.Y.5
-
125
-
-
50149120755
-
A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients
-
D.Z. Xu, K. Zhao, L.M. Guo, L.J. Li, Q. Xie, H. Ren, J.M. Zhang, M. Xu, H.F. Wang, W.X. Huang, X.F. Bai, J.Q. Niu, P. Liu, X.Y. Chen, X.L. Shen, Z.H. Yuan, X.Y. Wang, and Y.M. Wen A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients PLoS One 7 2008 e2565
-
(2008)
PLoS One
, vol.7
, pp. e2565
-
-
Xu, D.Z.1
Zhao, K.2
Guo, L.M.3
Li, L.J.4
Xie, Q.5
Ren, H.6
Zhang, J.M.7
Xu, M.8
Wang, H.F.9
Huang, W.X.10
Bai, X.F.11
Niu, J.Q.12
Liu, P.13
Chen, X.Y.14
Shen, X.L.15
Yuan, Z.H.16
Wang, X.Y.17
Wen, Y.M.18
-
126
-
-
84882811237
-
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
-
D.Z. Xu, X.Y. Wang, X.L. Shen, G.Z. Gong, H. Ren, L.M. Guo, A.M. Sun, M. Xu, L.J. Li, X.H. Guo, Z. Zhen, H.F. Wang, H.Y. Gong, C. Xu, N. Jiang, C. Pan, Z.J. Gong, J.M. Zhang, J. Shang, J. Xu, Q. Xie, T.F. Wu, W.X. Huang, Y.G. Li, J. Xu, Z.H. Yuan, B. Wang, K. Zhao, and Y.M. Wen Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings J. Hepatol. 3 2013 450 456
-
(2013)
J. Hepatol.
, vol.3
, pp. 450-456
-
-
Xu, D.Z.1
Wang, X.Y.2
Shen, X.L.3
Gong, G.Z.4
Ren, H.5
Guo, L.M.6
Sun, A.M.7
Xu, M.8
Li, L.J.9
Guo, X.H.10
Zhen, Z.11
Wang, H.F.12
Gong, H.Y.13
Xu, C.14
Jiang, N.15
Pan, C.16
Gong, Z.J.17
Zhang, J.M.18
Shang, J.19
Xu, J.20
Xie, Q.21
Wu, T.F.22
Huang, W.X.23
Li, Y.G.24
Xu, J.25
Yuan, Z.H.26
Wang, B.27
Zhao, K.28
Wen, Y.M.29
more..
-
127
-
-
84896934689
-
The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics
-
P. Xu, Y.J. Chen, H. Chen, X.Y. Zhu, H.F. Song, L.J. Cao, and X.F. Wang The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics Gut Liver 2 2014 186 195
-
(2014)
Gut Liver
, vol.2
, pp. 186-195
-
-
Xu, P.1
Chen, Y.J.2
Chen, H.3
Zhu, X.Y.4
Song, H.F.5
Cao, L.J.6
Wang, X.F.7
-
128
-
-
84899625639
-
Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion
-
Y.B. Xu, L. Yang, G.F. Wang, X.K. Tong, Y.J. Wang, Y. Yu, J.F. Jing, C.L. Feng, P.L. He, W. Lu, W. Tang, and J.P. Zuo Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion Antiviral Res. 2014 6 15
-
(2014)
Antiviral Res.
, pp. 6-15
-
-
Xu, Y.B.1
Yang, L.2
Wang, G.F.3
Tong, X.K.4
Wang, Y.J.5
Yu, Y.6
Jing, J.F.7
Feng, C.L.8
He, P.L.9
Lu, W.10
Tang, W.11
Zuo, J.P.12
-
129
-
-
84940515778
-
The Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion
-
R. Yan, X. Zhao, D. Cai, Y. Liu, T.M. Block, J.T. Guo, and H. Guo The Interferon-inducible protein tetherin inhibits hepatitis B virus virion secretion J. Virol. 18 2015 9200 9212
-
(2015)
J. Virol.
, vol.18
, pp. 9200-9212
-
-
Yan, R.1
Zhao, X.2
Cai, D.3
Liu, Y.4
Block, T.M.5
Guo, J.T.6
Guo, H.7
-
130
-
-
33846650945
-
Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients
-
X. Yao, B. Zheng, J. Zhou, D.Z. Xu, K. Zhao, S.H. Sun, Z.H. Yuan, and Y.M. Wen Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients Vaccine 10 2007 1771 1779
-
(2007)
Vaccine
, vol.10
, pp. 1771-1779
-
-
Yao, X.1
Zheng, B.2
Zhou, J.3
Xu, D.Z.4
Zhao, K.5
Sun, S.H.6
Yuan, Z.H.7
Wen, Y.M.8
-
131
-
-
80051865054
-
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion
-
W. Yu, C. Goddard, E. Clearfield, C. Mills, T. Xiao, H. Guo, J.D. Morrey, N.E. Motter, K. Zhao, T.M. Block, A. Cuconati, and X. Xu Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion J. Med. Chem. 16 2011 5660 5670
-
(2011)
J. Med. Chem.
, vol.16
, pp. 5660-5670
-
-
Yu, W.1
Goddard, C.2
Clearfield, E.3
Mills, C.4
Xiao, T.5
Guo, H.6
Morrey, J.D.7
Motter, N.E.8
Zhao, K.9
Block, T.M.10
Cuconati, A.11
Xu, X.12
-
132
-
-
84885445313
-
IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier
-
Z. Zeng, X. Kong, F. Li, H. Wei, R. Sun, and Z. Tian IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier J. Immunol. 8 2013 4184 4193
-
(2013)
J. Immunol.
, vol.8
, pp. 4184-4193
-
-
Zeng, Z.1
Kong, X.2
Li, F.3
Wei, H.4
Sun, R.5
Tian, Z.6
-
133
-
-
84921967768
-
Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection
-
E. Zhang, and M. Lu Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection Med. Microbiol. Immunol. 1 2015 11 20
-
(2015)
Med. Microbiol. Immunol.
, vol.1
, pp. 11-20
-
-
Zhang, E.1
Lu, M.2
-
134
-
-
80054095779
-
The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection
-
E. Zhang, X. Zhang, J. Liu, B. Wang, Y. Tian, A.D. Kosinska, Z. Ma, Y. Xu, U. Dittmer, M. Roggendorf, D. Yang, and M. Lu The expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infection PLoS One 10 2011 e26196
-
(2011)
PLoS One
, vol.10
, pp. e26196
-
-
Zhang, E.1
Zhang, X.2
Liu, J.3
Wang, B.4
Tian, Y.5
Kosinska, A.D.6
Ma, Z.7
Xu, Y.8
Dittmer, U.9
Roggendorf, M.10
Yang, D.11
Lu, M.12
-
135
-
-
84886502709
-
Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B
-
W.J. Zhang, C.H. Peng, and S.S. Zheng Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B Hepatobiliary Pancreat. Dis. Int. 4 2013 394 399
-
(2013)
Hepatobiliary Pancreat. Dis. Int.
, vol.4
, pp. 394-399
-
-
Zhang, W.J.1
Peng, C.H.2
Zheng, S.S.3
-
136
-
-
84911374800
-
Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss
-
Q. Zheng, Y.Y. Zhu, J. Chen, Y.R. Liu, J. You, J. Dong, D.W. Zeng, L.Y. Gao, L.H. Chen, and J.J. Jiang Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss J. Viral Hepat. 12 2014 909 916
-
(2014)
J. Viral Hepat.
, vol.12
, pp. 909-916
-
-
Zheng, Q.1
Zhu, Y.Y.2
Chen, J.3
Liu, Y.R.4
You, J.5
Dong, J.6
Zeng, D.W.7
Gao, L.Y.8
Chen, L.H.9
Jiang, J.J.10
-
137
-
-
84929518278
-
Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection
-
Q. Zheng, Y.Y. Zhu, J. Chen, Y.B. Ye, J.Y. Li, Y.R. Liu, M.L. Hu, Y.C. Zheng, and J.J. Jiang Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection Clin. Exp. Immunol. 3 2015 499 508
-
(2015)
Clin. Exp. Immunol.
, vol.3
, pp. 499-508
-
-
Zheng, Q.1
Zhu, Y.Y.2
Chen, J.3
Ye, Y.B.4
Li, J.Y.5
Liu, Y.R.6
Hu, M.L.7
Zheng, Y.C.8
Jiang, J.J.9
-
138
-
-
84923769732
-
Antiviral therapies and prospects for a cure of chronic hepatitis B
-
F. Zoulim, and D. Durantel Antiviral therapies and prospects for a cure of chronic hepatitis B Cold Spring Harb. Perspect. Med. 2015 4
-
(2015)
Cold Spring Harb. Perspect. Med.
, pp. 4
-
-
Zoulim, F.1
Durantel, D.2
-
139
-
-
70350095437
-
Hepatitis B virus resistance to nucleos(t)ide analogues
-
F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 5 2009 1593 1608
-
(2009)
Gastroenterology
, vol.5
, pp. 1593-1608
-
-
Zoulim, F.1
Locarnini, S.2
|